SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
about
The role of death-associated protein 3 in apoptosis, anoikis and human cancerHistone deacetylase inhibitor sensitizes apoptosis-resistant melanomas to cytotoxic human T lymphocytes through regulation of TRAIL/DR5 pathway.Augmenting antitumor immune responses with epigenetic modifying agents.Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells.Epigenetic regulation of the TRAIL/Apo2L apoptotic pathway by histone deacetylase inhibitors: an attractive approach to bypass melanoma immunotherapy resistanceThe histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells.Suberoylanilide hydroxamic acid-induced specific epigenetic regulation controls Leptin-induced proliferation of breast cancer cell lines.FLIP: molecular switch between apoptosis and necroptosis.Epigenetic mechanisms of breast cancer: an update of the current knowledge.Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NFκβ pathways.The synergistic effect of SAHA and parthenolide in MDA-MB231 breast cancer cells.Basic nuclear processes affected by histone acetyltransferases and histone deacetylase inhibitors.Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and PromisesTRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA.
P2860
Q34043792-93A1FD43-687B-44B6-BF40-9E94811EB52EQ34060387-5B724FA7-6940-4C34-B56D-36F14F3D986CQ35048054-0D19AE2D-163C-48EE-AE03-5100912E2438Q36996317-D0381590-8394-4577-916A-4AA45D408BFFQ37021699-376CFFEF-2867-4AFE-81E5-536BC075336AQ37301688-1B639B05-4148-4EE0-BB49-10EB945A764FQ37709475-83FFF68F-23E4-422C-806D-2739B11B11CFQ38102627-5B96A141-AF00-4F2B-8D3D-CFEA7592D8B1Q38296760-A1E7FA6E-C94B-4E66-B5B6-33C09E2EB52AQ38790660-950E5A72-9DCE-47A3-AC35-0ADD24BC037CQ38942706-13ABA702-2050-4683-9F6F-E9FBBB9542E6Q39118730-C077EEDD-D634-4A4C-9A37-DC6856B32A8EQ41664067-561F9272-54AC-4503-84CD-00A357911E63Q41987802-57D99B40-1B06-4CDC-ADB0-F7F9109A1279
P2860
SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@en
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@nl
type
label
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@en
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@nl
prefLabel
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@en
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells.
@nl
P2093
P1433
P1476
SAHA/TRAIL combination induces ...... and MCF-7 breast cancer cells
@en
P2093
G Tesoriere
M Lauricella
P304
P356
10.1016/J.BIOCHI.2011.06.031
P577
2011-07-31T00:00:00Z